1.
Anatomical heterogeneity of residual disease in chronic lymphocytic leukemia treated with ibrutinib.
Hematol Oncol
; 40(5): 1105-1108, 2022 12.
Article
in English
| MEDLINE
| ID: mdl-35656838
2.
Hematol Oncol
; 40(5): 1100-1104, 2022 12.
Article
in English
| MEDLINE
| ID: mdl-35613703